25 results
DEF 14A
IMCR
Immunocore Holdings plc
12 Apr 24
Definitive proxy
4:20pm
full power and authority to adopt, amend, terminate, and administer our equity award, pension, and profit sharing plans, incentive plans, bonus plans … provided by our independent compensation consultant.
Performance Bonus (at-risk cash)
Motivates and rewards for attaining rigorous annual corporate
PRE 14A
IMCR
Immunocore Holdings plc
2 Apr 24
Preliminary proxy
4:45pm
plans, bonus plans, executive benefit plans, stock purchase plans, deferred compensation plans and other similar programs;
when required, reviewing … by our independent compensation consultant.
Performance Bonus (at-risk cash)
Motivates and rewards for attaining rigorous annual corporate performance
10-K
2023 FY
EX-10.14
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
be eligible to receive an annual performance bonus (the “Annual Bonus”) with an annual target of 40% (the “Target Percentage”) of your then-current Base … Salary (the “Target Bonus”). The Annual Bonus will be based upon the assessment of the Board of Directors (the “Board”) of Immunocore Holdings Plc
10-K
2023 FY
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
rating is used to determine compensation awards, including yearly salary increase, bonus payment, and equity option award (offered to every single
10-K
2023 FY
EX-10.13
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
standard payroll practices (the “Base Salary”).
2.2 Bonus.
(a) During Employment. Executive shall be eligible to receive an annual performance bonus … (the “Annual Bonus”) with an annual target of 40% (the “Target Percentage”) of Executive’s then-current Base Salary (the “Target Bonus”). The Annual
10-K
EX-10.12
giu8vm zhlhh
28 Feb 24
Annual report
7:33am
6-K/A
EX-99.1
9d7pcbu3th81
18 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
4:17pm
6-K
EX-99.1
681h9p9s1ipd
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-99.1
mxydlzoq
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
EX-99.1
5mla2t7v79 2t
20 Jul 22
Securities Purchase Agreement
4:06pm
6-K
EX-99.2
1tthz xchf
11 May 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:08am
6-K
EX-99.1
7xwnf
11 May 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:08am
20-F
EX-1.1
b08lzjr78akk17
25 Mar 21
Annual report (foreign)
7:01am
20-F
EX-4.20
io4nboua 4w9nw9jpo
25 Mar 21
Annual report (foreign)
7:01am
20-F
qms402j0 ys
25 Mar 21
Annual report (foreign)
7:01am
424B4
cq01rl97k4qj7f7rp96
8 Feb 21
Prospectus supplement with pricing info
8:36am
F-1/A
EX-1.1
96rm80xh
3 Feb 21
Registration statement (foreign) (amended)
5:22pm
F-1/A
wt2pt4 9nhizgf
3 Feb 21
Registration statement (foreign) (amended)
5:22pm
F-1/A
EX-3.1
xs8uy4b
1 Feb 21
Registration statement (foreign) (amended)
6:21am